Summary of Findings Table ‐ DaxibotulinumtoxinA 40U vs placebo
Major adverse events · glabellar lines
1 finding from 1 review
- no estimate extracted2 studies · 716 participantsModerate
Summary of Findings Table ‐ DaxibotulinumtoxinA 40U probably leads to higher total adverse events compared with placebo (moderate certainty).
Summary of Findings Table ‐ AbobotulinumtoxinA 50U showed no clear difference in major adverse events (eyelid ptosis, eyelid sensory disorder,… compared with placebo (moderate certainty).
The review found no eligible studies for this question.
BoNT‐A showed no clear difference in adverse events compared with placebo or sham (moderate certainty).
BoNT‐A showed no clear difference in adverse events compared with serial casting (low certainty).
The review found no eligible studies for this question.